Southern Acids (Malaysia) Bhd.
MMYX:SAB3.08
MYR
0.00
(0.00%)
ISIN
MYL5134OO001
Return %
Stock
S&P 500
1Y
-5.23
14.20
3Y
-5.23
81.12
5Y
-21.83
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Kok Thye Low
- Full Time Employees
- 1,883
- Sector
- Miscellaneous
- Industry
- Miscellaneous
- Address
- Klang Malaysia
- IPO Date
- Jul 10, 1991
- Website
- southernacids.com
- Similar Companies
- Business
- Southern Acids (Malaysia) Berhad is a Malaysia-based diversified investment holding company primarily engaged in the manufacturing and marketing of palm-based oleochemical products, oil palm cultivation and milling, and the provision of private tertiary healthcare services. Founded in 1980 and headquartered in Klang, Selangor, Malaysia, the group operates across four core business segments: Oleochemical Manufacturing, Milling and Cultivation, Healthcare Services, and Investments and Services. Through its manufacturing subsidiary, Southern Acids Industries Sdn. Bhd. in Kapar, the company produces and markets a specialized portfolio of palm-based oleochemicals; including fractionated and distilled fatty acids such as stearic acid, palmitic acid, myristic acid, lauric acid, and oleic acid; and refined glycerine in pharmaceutical, food, and technical grades, serving domestic and export markets across personal care, cosmetics, pharmaceuticals, food manufacturing, and industrial detergents. In its Milling and Cultivation segment, the company manages oil palm plantation estates and operates two palm oil mills located in Riau Province, Indonesia, processing fresh fruit bunches into crude palm oil and palm kernel. Through its Healthcare Services division, the group owns and operates Sri Kota Specialist Medical Centre, a multi-disciplinary tertiary hospital in Klang, Selangor, providing medical, surgical, and diagnostic services across core specialties such as cardiology, spinal care, oncology, orthopedics, and general surgery. Its Investments and Services segment encompasses plantation management, internal port cargo handling, warehousing, and commercial property leasing. In recent operational and corporate developments, Southern Acids (Malaysia) Berhad has advanced structured oil palm replanting programs across its Indonesian estates to improve tree age profile and long-term crop yields; initiated efficiency and environmental upgrades across its Kapar oleochemical processing lines to strengthen compliance with Roundtable on Sustainable Palm Oil (RSPO) standards and manage raw material volatility; upgraded clinical diagnostic technologies and medical infrastructure at Sri Kota Specialist Medical Centre; and enacted routine board governance and committee reconstitutions while maintaining sustained shareholder capital returns through regular dividend distributions.